Page 6 - மரபியல் தனிப்பயனாக்கப்பட்டது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மரபியல் தனிப்பயனாக்கப்பட்டது ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மரபியல் தனிப்பயனாக்கப்பட்டது ஆரோக்கியம் Today - Breaking & Trending Today

New method for genome assembly in barley provides excellent results


New publication by iDiv member at IPK Leibniz Institute
Based on a press release by IPK Leibniz Institute
Gatersleben. Genomes differ between the individuals of one species and we can learn a lot about diversity in our crops by comparing genomes of different varieties. However, researchers that want to study many genomes need a fast and reliable method for sequence assembly. An international research team led by the IPK Leibniz Institute has now investigated a new DNA sequencing method. The results, which have now been published in the journal The Plant Cell, are very promising. The scientists now hope to be able to use the method for assembling other barley genomes in the future. ....

Sachsen Anhalt , Nils Stein , Uwe Scholz , Martin Mascher , Thomas Lux , Andrewg Sharpe , Jerry Jenkins , Jeremy Schmutz , Samuel Holden , Manuel Spannagl , Curtisj Pozniak , Klausfx Mayer , Christopher Plott , Chu Shin Koh , Inmaculada Hern , Jane Grimwood , Heidrun Gundlach , Zuzana Tulpov , Leibniz Institute , Group On Domestication Genomics , German Center , Integrative Biodiversity Research , Leibniz Institute In Gatersleben , Plant Cell , Independent Working Group , Domestication Genomics ,

Researchers Provide Complete Clinical Landscape for Major Gene Linked to Epilepsy and Autism


Date Time
Researchers Provide Complete Clinical Landscape for Major Gene Linked to Epilepsy and Autism
Researchers from Children’s Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) have compiled a complete genetic and clinical analysis of more than 400 individuals with SCN2A-related disorder, which has been linked to a variety of neurodevelopmental disorders, including epilepsy and autism. By linking clinical features to genetic abnormalities in a standardized format, the researchers hope their findings lead to improved identification and clinical intervention.
The study was published online by the journal Genetics in Medicine.
Pathogenic variants in the SCN2A gene can lead to a wide range of clinical features – or phenotypes – associated with neurodevelopmental disorders. Several studies have described the genetic information collected on individuals with disease-causing changes in this gene. However, while g ....

United States , Ingo Helbig , Human Development , Epilepsy Syndrome Consortium , National Center , Institute For Translational Medicine , International League Against Epilepsy , Epilepsy Neurogenetics Initiative , Research Center , Clinical Phd Academy , Research Unit , Innovation Network , Genomics Research , German Research Foundation , National Institute For Neurological Disorders , Chartwell Foundation , Neurogenetics Initiative , Human Phenotype Ontology , National Institute , Neurological Disorders , Channelopathy Associated Research Center , Eunice Kennedy Shriver National Institute , Child Health , Advancing Translational Sciences , National Institutes , Translational Medicine ,

The Human Genome Project celebrates its 20th anniversary


Download 8.90 MB
In February 2001, humanity got its first look at the human genome following the publication of the Human Genome Project, one of the largest scientific projects ever undertaken.
The Human Genome Project fundamentally changed genomics, medical research and collaboration in science, it also opened up the field of epigenetics and the possibility of personalised medicine.
What have been the biggest project s contributions to human health, and where are the future avenues of research?
GUEST: Professor John Shine, former Executive Director of the Garvan Institute of Medical Research and President of the Australian Academy of Science.
Duration: 9min 43sec ....

Garvan Institute Of Medical Research , Australian Academy Of Science , Human Genome Project , Professor John Shine , Executive Director , Garvan Institute , Medical Research , Australian Academy , Collaborative Science , கார்வான் நிறுவனம் ஆஃப் மருத்துவ ஆராய்ச்சி , ஆஸ்திரேலிய கலைக்கழகம் ஆஃப் அறிவியல் , மனிதன் மரபணு ப்ராஜெக்ட் , ப்ரொஃபெஸர் ஜான் பிரகாசிக்கவும் , நிர்வாகி இயக்குனர் , கார்வான் நிறுவனம் , மருத்துவ ஆராய்ச்சி , ஆஸ்திரேலிய கலைக்கழகம் , கூட்டு அறிவியல் ,

UAE's health ministry urges Emiratis to participate in
national genomics study to combat genetic diseases


March 16, 2021
The health ministry in the United Arab Emirates has called upon all citizens to participate in the Emirati Genome Program, a ground-breaking national genomics initiative and one of the world’s largest, and most comprehensive genomics programs. Courtesy photo
ABU DHABI The health ministry in the United Arab Emirates has called upon all citizens to participate in the Emirati Genome Program, a ground-breaking national genomics initiative and one of the world’s largest, and most comprehensive genomics programs.
The program aims to provide the best healthcare system for all Emirati citizens, understand the nature of the genetic diseases prevalent among the UAE population, implement personalized medicine for Emiratis to provide accurate diagnosis and appropriate treatment, strengthen the prevention of genetic and chronic diseases in the coming generations, equip national competencies to reshape the future of healthcare policies in c ....

United Arab Emirates , Abu Dhabi , Ashish Koshy , Al Owais , Al Maared Hall , Emirati Genome Programme , Omics Centre Of Excellence , Department Of Health , Biogenix Lab Masdar City , Abu Dhabi National Exhibition Centre , Emirati Genome Program , Global Competitiveness , Omics Centre , Abdul Rahman , Nasser Al Owais , Chief Executive Officer , Genome Program , Saudigazette Newspaper , Saudi Sazette , Saudi Gazette , Saudi Arabia , Kingdom Of Saudi Arabia , Latest News , King Salman , ஒன்றுபட்டது அரபு அமீரகங்கள் , ஆஷிஷ் கோஷி ,

License provides Access to Genome Editing Platform


Mar 15 2021 Read 334 Times
G+FLAS Life Sciences, has been granted a non-exclusive license agreement to access to ERS Genomics’ CRISPR/Cas9 patent portfolio. The Korean biotech (Seoul) produces research tools and reagents under ISO 13485 and ISO 9001 and is applying CRISPR PLUS technology to the development of drugs and production of CRISPR genome edited plants in a non-GMO way.
ERS Genomics holds an exclusive worldwide license from co-founder and recent Nobel prize winner Dr. Emmanuelle Charpentier to the foundational intellectual property covering CRISPR/Cas9 for use as a research platform.
“G+FLAS is developing genome editing applications using CRISPR/Cas9 that will further expand the reach of this important gene editing tool,” said Eric Rhodes, CEO of ERS Genomics. “We are pleased to provide access to this Nobel Prize winning technology and look forward to seeing G+FLAS continue in its mission.” ....

Soult Ukpyolsi , South Korea , Sunghwa Choe , Emmanuelle Charpentier , Eric Rhodes , Life Sciences , Nobel Prize , தெற்கு கொரியா , இம்மானுவேல் சார்பென்டிர் , எரிக் ரோட்ஸ் , வாழ்க்கை அறிவியல் , நோபல் ப்ரைஸ் ,